Public Health Agency of Canada
www.publichealth.gc.ca
Common menu bar links
The Canadian Nosocomial Infection Surveillance Program
Point Prevalence Study
All HAI |
UTI |
Pneumonia |
SSI |
BSI |
CDAD |
|||||||
| Medical Unit | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % |
| All units, n= 5750 | 667 | 11.6 | 194 | 3.4 | 175 | 3.1 | 146 | 2.5 | 93 | 1.6 | 59 | 1 |
| Critical care, n = 462 | 153 | 33.2 | 20 | 4.3 | 72 | 15.6 | 22 | 4.8 | 34 | 7.4 | 5 | 1.1 |
| Trauma and Burn, n = 97 | 17 | 17.6 | 4 | 4.1 | 5 | 5.2 | 5 | 5.2 | 3 | 3.1 | 0 | 0 |
| Transplant, n = 82 | 12 | 14.7 | 3 | 3.7 | 5 | 6.1 | 1 | 1.2 | 3 | 3.7 | 0 | 0 |
| Surgery, n = 2112 | 247 | 11.7 | 79 | 3.7 | 39 | 1.9 | 99 | 4.7 | 13 | 0.6 | 17 | 0.8 |
| Oncology/Hematology, n =250 | 28 | 11.2 | 6 | 2.4 | 7 | 2.8 | 0 | 0 | 9 | 3.6 | 6 | 2.4 |
| Gynecology/Obstetrics, n =118 | 13 | 11 | 5 | 4.2 | 0 | 0 | 4 | 3.4 | 4 | 3.4 | 0 | 0 |
| Medicine, n = 2619 | 197 | 7.5 | 77 | 2.9 | 47 | 1.8 | 15 | 0.6 | 27 | 1 | 31 | 1.2 |
| Other, n = 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Medicine n = 2619 |
Surgery n = 2112 |
Critical Care n = 462 |
Hem/Onc n = 250 |
Transplant n = 82 |
Other n = 225 |
Total N = 5750 |
||||||||
| Drug Classification | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % |
| Aminoglycosides | 41 | 1.6 | 35 | 1.7 | 11 | 2.4 | 16 | 6.4 | 0 | 0 | 5 | 2.2 | 108 | 1.9 |
| Antifungal agents | 21 | 0.8 | 23 | 1.1 | 25 | 5.5 | 40 | 16 | 12 | 14.6 | 2 | 0.9 | 123 | 2.1 |
| Antituberculosis agents | 32 | 1.2 | 10 | 0.5 | 6 | 1.3 | 4 | 1.6 | 0 | 0 | 0 | 0 | 52 | 0.9 |
| Carbapenems | 17 | 0.6 | 21 | 1.1 | 17 | 3.7 | 15 | 6 | 5 | 6.1 | 6 | 2.6 | 81 | 1.4 |
| Cephalosporins 1st generation | 88 | 3.4 | 205 | 9.7 | 28 | 6.1 | 8 | 3.2 | 4 | 4.9 | 12 | 5.2 | 345 | 6 |
| Cephalosporins 2nd generation | 37 | 1.4 | 11 | 0.5 | 8 | 1.7 | 0 | 0 | 1 | 1.2 | 3 | 1.3 | 60 | 1 |
| Cephalosporins 3rd/4th generation | 122 | 4.7 | 59 | 2.8 | 35 | 7.6 | 23 | 9.2 | 10 | 12.2 | 4 | 1.7 | 253 | 4.4 |
| Fluoroquinolones | 297 | 11.3 | 194 | 9.2 | 61 | 13.3 | 39 | 15.6 | 11 | 13.4 | 6 | 2.6 | 608 | 10.6 |
| Vancomycin | 81 | 3.1 | 64 | 3 | 43 | 9.4 | 27 | 10.8 | 5 | 6.1 | 5 | 2.2 | 225 | 3.9 |
| Clindamycin | 29 | 1.1 | 38 | 1.8 | 12 | 2.6 | 2 | 0.8 | 1 | 1.2 | 1 | 0.4 | 83 | 1.4 |
| Macrolides | 41 | 1.6 | 11 | 0.5 | 13 | 2.8 | 2 | 0.8 | 0 | 0 | 1 | 0.4 | 68 | 1.2 |
| Metronidazole | 141 | 5.4 | 164 | 7.8 | 34 | 7.4 | 27 | 10.8 | 8 | 9.8 | 3 | 1.3 | 377 | 6.6 |
| Penicillins | 151 | 5.8 | 124 | 5.9 | 50 | 10.9 | 38 | 15.2 | 4 | 4.9 | 4 | 1.6 | 371 | 6.5 |
| Others | 80 | 3.1 | 84 | 4 | 12 | 2.6 | 44 | 17.6 | 37 | 45.1 | 2 | 0.8 | 259 | 4.5 |
Back to Point Prevalence Study
To share this page just click on the social network icon of your choice.